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Anna Torres1*, Joanna Kozak1, Agnieszka Korolczuk2, Paulina Wdowiak1, Ewa Domańska-Glonek1,
Ryszard Maciejewski3 and Kamil Torres3Erratum
After the publication of the article [1], the authors realised
it contained an error with the Methods section. The fol-
lowing paragraph should be deleted from the original
article:
Cell proliferation assay
Proliferation was measured using Delfia cell proliferation
kit (Perkin-Elmer, Waltham, MA, USA) according to
manufacturer protocol. BrdU incorporation was measured
by time–resolved fluorescence 48 h after transfection
using VictorX4 multimode plate reader (Perkin-Elmer,
Waltham, MA, USA). All experiments were performed in
triplicates and repeated tree times.
Please note that the original article was corrected.
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